Altered Iron Metabolism and Ferroptosis in Polycystic Ovary Syndrome: Insights from a Meta-Analysis and Case-Control Study in Pregnant Women - Scorecard - MDSpire
Clinical Scorecard: Altered Iron Metabolism and Ferroptosis in Polycystic Ovary Syndrome: Insights from a Meta-Analysis and Case-Control Study in Pregnant Women
At a Glance
Category
Detail
Condition
Polycystic Ovary Syndrome (PCOS)
Key Mechanisms
Altered iron metabolism and ferroptosis linked to oxidative stress and adverse pregnancy outcomes.
Target Population
Women of reproductive age with PCOS, particularly during pregnancy.
Care Setting
Obstetric and gynecological care settings.
Key Highlights
PCOS affects 7-12% of women of reproductive age.
Associated with adverse pregnancy outcomes like miscarriage and gestational diabetes.
Elevated serum ferritin and reduced hepcidin levels observed in women with PCOS.
Ferroptosis may play a role in ovarian follicular atresia and pregnancy complications.
Meta-analysis and case-control study conducted to explore iron metabolism in PCOS.
Guideline-Based Recommendations
Diagnosis
Diagnosis of PCOS confirmed via Rotterdam criteria: oligomenorrhea/anovulation, hyperandrogenism, and polycystic ovaries.
Management
Investigate ferroptosis as a potential therapeutic strategy for managing ovulation in PCOS.
Monitoring & Follow-up
Monitor serum ferritin and hepcidin levels in pregnant women with PCOS.
Risks
Increased risk of miscarriage, preterm delivery, and gestational diabetes in women with PCOS.
Patient & Prescribing Data
Pregnant women aged 18-45 with singleton pregnancies and diagnosed with PCOS.
Potential for targeting ferroptosis in therapeutic approaches for PCOS-related complications.
Clinical Best Practices
Conduct thorough screening for PCOS in women presenting with reproductive issues.
Utilize biomarkers of iron metabolism for assessing risks in pregnant women with PCOS.
Incorporate multidisciplinary approaches for managing PCOS and associated pregnancy complications.
